BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pandita P, Wang X, Jones DE, Collins K, Hawkins SM. Unique Molecular Features in High-Risk Histology Endometrial Cancers. Cancers (Basel) 2019;11:E1665. [PMID: 31717878 DOI: 10.3390/cancers11111665] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Rubinstein M, Shen S, Monk BJ, Tan DS, Nogueira-rodrigues A, Aoki D, Sehouli J, Makker V. Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer. Gynecologic Oncology 2022. [DOI: 10.1016/j.ygyno.2022.10.012] [Reference Citation Analysis]
2 Cho-Clark MJ, Sukumar G, Vidal NM, Raiciulescu S, Oyola MG, Olsen C, Mariño-Ramírez L, Dalgard CL, Wu TJ. Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression. Oncotarget 2021;12:2500-13. [PMID: 34966482 DOI: 10.18632/oncotarget.28161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang X, Praça MSL, Wendel JRH, Emerson RE, DeMayo FJ, Lydon JP, Hawkins SM. Vaginal Squamous Cell Carcinoma Develops in Mice with Conditional Arid1a Loss and Gain of Oncogenic Kras Driven by Progesterone Receptor Cre. Am J Pathol 2021;191:1281-91. [PMID: 33882289 DOI: 10.1016/j.ajpath.2021.03.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Han Z, Zheng Z, Tao K, Yu Y, Wu J, Tian X. The effect of surgical approach on the outcomes and prognosis of high-risk histologic endometrioid carcinomas. Gland Surg 2021;10:355-63. [PMID: 33633992 DOI: 10.21037/gs-20-887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wang X, Praça MSL, Wendel JRH, Emerson RE, Demayo FJ, Lydon JP, Hawkins SM. Vaginal squamous cell carcinoma develops in mice with Arid1a loss and gain of oncogenic Kras.. [DOI: 10.1101/2020.12.15.422959] [Reference Citation Analysis]
6 Králíčková M, Vetvicka V, Laganà AS. Endometrial cancer-is our knowledge changing? Transl Cancer Res 2020;9:7734-45. [PMID: 35117376 DOI: 10.21037/tcr-20-1720] [Reference Citation Analysis]
7 Ko EM, Brensinger CM, Cory L, Giuntoli RL 2nd, Haggerty AF, Latif NA, Aviles D, Martin L, Morgan MA, Lin LL. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology. Gynecol Oncol 2020;159:394-401. [PMID: 32800655 DOI: 10.1016/j.ygyno.2020.07.105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Nasioudis D, Roy AG, Ko EM, Cory L, Giuntoli Ii RL, Haggerty AF, Kim SH, Morgan MA, Latif NA. Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium. Int J Gynecol Cancer 2020;30:1089-94. [DOI: 10.1136/ijgc-2020-001379] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
9 Wang X, Wendel JRH, Emerson RE, Broaddus RR, Creighton C, Rusch DB, Buechlein A, Demayo FJ, Lydon JP, Hawkins SM. PtenandDicer1loss causes poorly-differentiated endometrial adenocarcinoma in mice.. [DOI: 10.1101/2020.03.12.989087] [Reference Citation Analysis]